South Centre News on AMR 6, 28 September 2017
Alarm as ‘super malaria’ spreads in South East Asia
Social Development
South Centre News on AMR 5, 20 September 2017
World running out of antibiotics, says WHO in new reports
SC Side Event to the UNGA 72, 18 September 2017
Title: The Elaboration of a Legally Binding Instrument on Transnational Corporations and Other Business Enterprises
Date: Monday, 18 September 2017
Venue: UN Headquarters, New York
Organizers: The South Centre, Permanent Missions of Ecuador and South Africa to the United Nations in New York
DIIP Monthly Update – August 2017
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of August 2017.
South Centre News on AMR 4, 6 September 2017
Growing impetus to making AMR an integral issue in the 2030 Agenda for Sustainable Development
South Centre News on AMR 3, 28 August 2017
Antibiotic-resistant gonorrhea crisis: new drugs needed
South Centre News on AMR 2, 22 August 2017
State of discussion on AMR action, two years after the WHA Global Plan
South Centre News on AMR 1, 9 August 2017
Civil society and South Centre call for urgent actions to tackle AMR and ensure access and new innovation models
South Centre News on AMR, 7 August 2017
SOUTH CENTRE NEWS ON AMR is a service of the South Centre to provide news and information on issues relating to Antimicrobial Resistance.
Analytical Note, July 2017
The WTO’s Fisheries Subsidies Negotiations
Attempts are made to revitalise the fisheries subsidies negotiations at the WTO with the aim of achieving an outcome at the 11th WTO Ministerial Conference in December 2017.
DIIP Monthly Update – July 2017
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of July 2017.
Research Paper 62R, July 2017
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines (revised)
Most free trade agreements (FTAs) signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization (WTO). (more…)